Wiraxon

Founded in 2025 and based in Shanghai, China, Wiraxon (Shanghai) Medical Devices Co. , Ltd. provides neural pathway reconstruction devices for the healthcare sector. The company commercializes brain spine interface technology developed through scientific research at Fudan University.

Associate researcher Fumin Jia supports the clinical translation and development of the platform. In May 2026, the firm raised over CNY 300 million in angel funding. It develops implantable brain-spinal nerve stimulation systems based on the core principles of "minimally invasive + low latency + high integration," enabling rapid motor function reconstruction in paraplegic patients and establishing brain-computer interfaces as a benchmark product in the rehabilitation medicine field. The company generates revenue from B2B contracts through the distribution of its implantable medical hardware, electrode chips, and licensed signal decoding software to healthcare institutions.

The company plans to use the angel funding to support multicenter registration clinical trials for its implantable brain spine interface technology, construct its headquarters in the Waigaoqiao area of Pudong, and advance its global strategic layout.